Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market
Highlights: Duopharma Biotech Berhad has been awarded the 2022 Malaysian Company of the Year by Frost & Sullivan for its pioneering efforts in the research and development of halal pharmaceuticals. The company aims to produce safe, effective, and high-quality Halal products, catering to Muslim consumers and setting industry standards in Malaysia. Their flagship product, ERYSAA®, a halal biosimilar erythropoietin for treating anemia in chronic kidney disease, has been successful in the market, and the company is continuously expanding and improving its Halal portfolio to stay ahead of competitors. Duopharma Biotech is also actively involved in promoting halal pharmaceutical awareness campaigns and exploring international collaborations, with plans to expand to other markets, including the United Arab Emirates (UAE). The company’s commitment to customer service and quality has resulted in high customer satisfaction ratings. Frost & Sullivan’s recognition highlights Duopharma Biotech’s excellence in growth strategy, innovation, and market penetration in the halal pharmaceutical industry.
Link to Original Article: